SAMUEL CHARACHE, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Sickle-cell anemia has become a topic of intense public interest; newspaper columnists, college students, baseball players, and Marcus Welby have devoted attention to it. The Congress has also paid attention, and it seems possible that more than 100 million dollars will be appropriated to "fight" this disease. Contrary to public opinion, research in this area has not been lacking in the past, although the anticipated influx of money has awakened much new interest. We now understand more about the pathogenesis of the illness, from molecule to man, than we do about that of almost any other disease (1). Like many
CHARACHE S. Sickle-Cell Anemia: The Known and the Unknown. Ann Intern Med. 1972;77:148–149. doi: https://doi.org/10.7326/0003-4819-77-1-148
Download citation file:
Published: Ann Intern Med. 1972;77(1):148-149.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use